Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
OBJECTIVES: To evaluate the association between improvements in physical function, fatigue and pain and improvements in productivity at work and at home in patients treated with certolizumab pegol (CZP) in combination with MTX. METHODS: Physical function, fatigue and pain were assessed in two CZP c...
Κύριοι συγγραφείς: | Hazes, J, Taylor, P, Strand, V, Purcaru, O, Coteur, G, Mease, P |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2010
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Certolizumab pegol in therapy for rheumatoid arthritis
ανά: Galina Viktorovna Lukina, κ.ά.
Έκδοση: (2012-06-01) -
COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
ανά: Purcaru, O, κ.ά.
Έκδοση: (2010) -
QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
ανά: Vera Nikolayevna Amirdjanova, κ.ά.
Έκδοση: (2012-10-01) -
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
ανά: M Connock, κ.ά.
Έκδοση: (2010-10-01) -
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
ανά: Ruiz Garcia, V, κ.ά.
Έκδοση: (2014)